Treatment of severe, nonfulminant acute hepatitis B with lamivudinevsplacebo: a prospective randomized double-blinded multicentre trial

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial

(2013) Katja Deterding et al.   LANCET INFECTIOUS DISEASES

Effects of Nucleoside Analogue on Patients with Chronic Hepatitis B-Associated Liver Failure: Meta-Analysis

(2013) Feng Xie et al.   PLoS One

Lamivudine treatment for severe acute HBV hepatitis

(2012) Andrea Lisotti et al.   International Journal of Medical Sciences

Lamivudine treatment is associated with improved survival in fulminant hepatitis B

(2011) Jian-Wu Yu et al.   LIVER INTERNATIONAL

Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?

(2011) Hans L. Tillmann et al.   LIVER INTERNATIONAL

Aktualisierung der S 3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion

(2011) M. Cornberg et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Trends of acute hepatitis B hospitalizations, comorbidities, fatality rate, and costs associated with the hospitalization in Spain (2001–2006)

(2010) Alejandro Arteaga-Rodríguez et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Acute hepatitis B in Japan: Incidence, clinical practices and health policy

(2010) Akahito Sako et al.   HEPATOLOGY RESEARCH

Favorable Outcome of Severe Acute Hepatitis B in a Patient Treated with Antithrombin III and Antiviral Therapy

(2009) Pavel Chalupa et al.   CLINICAL INFECTIOUS DISEASES

The Study of Efficacy of Lamivudine in Patients with Severe Acute Hepatitis B

(2009) Jian-Wu Yu et al.   DIGESTIVE DISEASES AND SCIENCES